SAXAGLIPTIN (has an active metabolite) | SAXAGLIPTIN | ATC A10BD10 ATC A10BD25 ATC A10BH03 ATC A10BD21
ANTIDIABETIC DIPEPTIDYL-PEPTIDASE IV INHIBITOR HYPOGLYCEMIC AGENTS TYPE 2 DIABETES MELLITUS METABOLISM METABOLITE OF SAXAGLIPTIN IS ONE-HALF AS POTENT AS SAXAGLIPTIN AS DPP4 INHIBITOR | ORAL | Cmax 76 NANOMOLAR (5 MILLIGRAM) VD 49.7 LITER (EQN) PPB 0 PERCENT Cl 13.8 LITER / HOUR HT 2.5 HOUR SOLUBILITY SPARINGLY SOLUBLE IN WATER | DIPEPTIDYL PEPTIDASE-4 (DPP-4) | Dipeptidyl peptidase 4 UNIPROT P27487 DPP4 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |